Radiotherapy-resistant breast cancer cell line, MDA-MB-231, shows a higher level of inflammasome activation through TNF-α/ATP/P2Y2R pathway than ordinary MDA-MB-231 [175]. Here, TNF is linked to breast carcinoma.